Predictors of No-Reflow Phenomenon: Diabetes Mellitus type II and Obesity and their Associated Mortality in Stemi Patients after Primary PCI
View Full Paper
Ask AI
Bookmark
Share
Why the study?
Do Type II diabetes mellitus and obesity predict the no-reflow phenomenon and increase mortality in STEMI patients undergoing primary PCI?
Population
656 patients with ST segment elevation acute myocardial infarction treated with primary percutaneous…
Comparison
Presence of Type II Diabetes Mellitus and/or… vs Absence of Type II Diabetes Mellitus and/or…
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
May warrant intensified monitoring in diabetic or obese STEMI patients with no-reflow; hypothesis-generating for targeted interventions.
Structured PICO
Do Type II diabetes mellitus and obesity predict the no-reflow phenomenon and increase mortality in STEMI patients undergoing primary PCI?
P
Population
656 patients with ST segment elevation acute myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
I
Intervention
Presence of Type II Diabetes Mellitus and/or Obesity (Exposure)
C
Comparator
Absence of Type II Diabetes Mellitus and/or Obesity (non-diabetic, normoponderal patients)
O
Outcome
Incidence of no-reflow phenomenon post-PCI and post-PCI mortalityhard clinical
Type II diabetes and severe obesity are significant predictors of the no-reflow phenomenon and are associated with increased post-PCI mortality in patients presenting with STEMI.
Cite This Study
Pantea-Roșan et al. (2019) studied this question.
View Full Paper
Ask AI
Bookmark
Share